McClung David Mark - Insider Non-Derivative Transactions at SANGAMO THERAPEUTICS, INC (SGMO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 25, 2023, McClung David Mark's relationship to SANGAMO THERAPEUTICS, INC (SGMO) is Officer (EVP, Chief Operating Officer), and currently has 212,471 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SGMO insiders.
Data Source: SEC.
McClung David Mark - Insider Non-Derivative Transactions of SGMO Common Stock
McClung David Mark - Insider Non-Derivative Transactions at SGMO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 26, 2023 | F -- (Common Stock) | 1925 | 0.38 | 212471 |
| Aug 26, 2023 | F -- (Common Stock) | 1925 | 0.77 | 214396 |
| Jun 26, 2023 | F -- (Common Stock) | 11528 | 1.19 | 211321 |
| May 26, 2023 | F -- (Common Stock) | 1925 | 1.33 | 222849 |
| Feb 26, 2023 | F -- (Common Stock) | 9745 | 2.66 | 224774 |
| Feb 25, 2023 | Acquisition -- (Common Stock) | 56250 | 0 | 234519 |